Genotypes of hepatitis C virus in chronic liver disease in Taiwan
Version of Record online: 7 DEC 2005
Copyright © 1994 Wiley-Liss, Inc., A Wiley Company
Journal of Medical Virology
Volume 44, Issue 3, pages 234–236, November 1994
How to Cite
Chen, C.-H., Sheu, J.-C., Wang, J.-T., Huang, G.-T., Yang, P.-M., Lee, H.-S., Lee, C.-Z. and Chen, D.-S. (1994), Genotypes of hepatitis C virus in chronic liver disease in Taiwan. J. Med. Virol., 44: 234–236. doi: 10.1002/jmv.1890440304
- Issue online: 7 DEC 2005
- Version of Record online: 7 DEC 2005
- Manuscript Accepted: 7 FEB 1994
- Department of Health, Executive Yuan, National Science Council
- Institute of Biomedical Sciences, Academia Sinica, R.O.C.
- hepatocellular carcinoma;
- liver cirrhosis;
- poly-merase chain reaction
The genotypes of hepatitis C virus (HCV) infection in 81 patients with liver cirrhosis (LC) or hepatocellular carcinoma (HCC) were investigated by the polymerase chain reaction using type-specific primers. All the patients were positive for HCV RNA in the serum. Forty-two patients had LC with HCC, while the remaining 39 patients had LC without HCC. Genotype II was detected in 47 samples (58.0%), type III in 6 samples (7.4%), and type IV in 4 (6.2%). No evidence of genotype I was found. Mixed infection was detected in 11 samples (13.6%). The prevalence of genotype II in LC with HCC patients (69.0%) was significantly higher (P < 0.05) than in the LC without HCC patients (46.2%). It is concluded that genotype II is the most predominant type in patients with LC or HCC in Taiwan, and is found more frequently in patients who had LC with HCC than in those who had LC alone. © 1994 Wiley-Liss, Inc.